Maximus publishes both a sermorelin injection offer and a detailed help-center overview. Reading them together is useful: the sales page emphasizes convenience and potential benefits, while the support page provides more context about clinical review, administration, and monitoring. The two kinds of information should not be treated as interchangeable.
We reviewed these public pages on September 20, 2026. This is an assessment of the documented offer and its limitations, not a patient experience or an independently verified outcome study. CoreAge Rx is our featured commercial partner, and its promoted placement is disclosed across the site.
Maximus documents an injection program and clinician-directed monitoring. Reconcile the monthly price with promotional daily figures and confirm your full care plan.
The product and price presented
The Maximus product page lists sermorelin injections starting at $199.99 per month. It describes online care, shipping, an injection kit, and access to a clinical support team. Those are the provider's offer statements, which should be confirmed for the selected plan.
The same page also uses per-day promotional language that does not line up cleanly with every monthly figure shown. A daily price can depend on a particular plan or promotion. Ask for the actual amount due today and the renewal amount rather than trying to reconstruct the bill from a daily slogan.
If $199.99 is the selected monthly rate, compare it with other programs over the same period and with the same included services. Do not assume that laboratory work, a second medicine, or a different hormone protocol is covered by that figure.
The help page identifies the administration route
The Sermorelin Protocol Overview, dated June 19, 2026, describes the Maximus program as a subcutaneous injection. Its statement about exclusive injection availability applies to that program, not to every sermorelin product in the market.
Ask for instructions matching the actual vial, concentration, and supplies dispensed. A public overview is useful background but should not replace the pharmacy label or a demonstration. Confirm who can help if syringe markings are difficult to see or if a refill's concentration changes.
For the practical questions to ask, see our injection guide. It covers training, route clarification, site questions, and disposal without providing a personal dosing plan.
How Maximus describes laboratory decisions
The help page says a clinician determines whether labs are needed based on symptoms, history, and goals. It also describes follow-up through check-ins, treatment updates, and laboratory work when appropriate. That is more specific than assuming either that everyone needs the same panel or that no one needs testing.
Ask what assessment would apply to you, whether you may need an endocrinology evaluation, and whether the relevant tests are included in the quoted cost. A statement that clinic or lab visits may not be needed does not establish that no assessment is necessary.
Our IGF-1 guide explains what one marker can and cannot show. Monitoring should connect to a clinical goal and safety plan, rather than simply pursuing a higher number.
Broader hormone programs can complicate a comparison
Maximus also discusses other hormone-related protocols. If more than one treatment is proposed, ask why each is included, whether the combination has direct supporting evidence, and which clinician will review the full plan.
Sermorelin is not testosterone replacement. The Endocrine Society testosterone guideline describes a separate diagnostic process for hypogonadism. Our men's health guide explains why libido, fatigue, or strength concerns should not automatically lead to a GH-related prescription.
Do not interpret access to several products as evidence that they should all be used together. Starting multiple interventions at once can make it harder to identify benefit or adverse effects.
Read the outcome claims carefully
The sales page refers to potential improvements in body composition, skin, recovery, and other wellness goals. The help page states that sermorelin is not a weight-loss medicine or a muscle-building drug. Those differences in emphasis are worth discussing with the clinician before deciding what result to expect.
The Endocrine Society aging statement distinguishes hormone changes from proven improvements in health and function. A testimonial about better sleep is not a controlled clinical estimate, and general research on growth hormone does not validate every compounded preparation.
Ask which studies match the exact treatment and patient group. The answer should include uncertainty, the expected size of any benefit, and when treatment would be reconsidered if the goal is not met.
Pharmacy, state access, and travel
Maximus describes dispensing through licensed U.S. compounding pharmacies. The FDA explains that compounded medicines are not FDA-approved, so that statement should not be read as agency approval of the finished product.
Confirm the pharmacy responsible for your prescription and the current state-availability rules. The help material notes that prescribing availability depends on physical location. If you travel or move, ask how follow-up and refills will work before the next supply is needed.
Storage instructions should come from the exact dispensing label. Do not transfer stability guidance between pharmacies or formulations merely because the active ingredient has the same name.
What to clarify before paying
Obtain the complete price, any minimum commitment, included testing, renewal timing, and cancellation policy. Ask how unused prepaid time or a clinical decision to stop is handled. Also ask which messages reach a clinician and which are handled by administrative support.
The CoreAge Rx review offers another program for comparison with our commercial relationship stated plainly. Maximus provides useful clinical support material, but its promotional prices and benefit claims still require careful interpretation. A clear personal plan should explain both the care you receive and the evidence supporting the decision to receive it.
Sources & further reading
Provider pages describe offers; they do not independently establish treatment benefits. Sources checked September 20, 2026.
This article is education, not a diagnosis, prescription, or dosing plan. Discuss treatment and alternatives with a licensed clinician who knows your history. Compounded medications are not FDA-approved.